ID
45814
Description
Principal Investigator: Craig L. Hanis, PhD, The University of Texas Health Science Center at Houston, Houston, TX, USA, USA MeSH: Diabetes Mellitus, Type 2 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001166 *The T2D Seq GWAS Starr County Cohort is utilized in the following dbGaP sub-studies.* To view genotypes, other molecular data, and derived variables collected in these sub-studies, please click on the following sub-studies below or in the "Sub-studies" section of this top-level study page phs001166 T2D Seq GWAS Starr County Cohort.- phs000143 CIDR T2D Hanis - phs001099 T2D GENES Starr County
Lien
Mots-clés
Versions (1)
- 29/06/2023 29/06/2023 - Simon Heim
Détendeur de droits
Craig L. Hanis, PhD, The University of Texas Health Science Center at Houston, Houston, TX, USA, USA
Téléchargé le
29 juin 2023
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs001166 Type 2 Diabetes Starr County GWAS and Exome Sequencing
Subject ID, case or control, age, gender, country of birth, BMI, waist of hip ratio, plasma cholesterol, plasma triglycerides, total plasma high density lipoprotein cholesterol, systolic and diastolic blood pressure, smoking, fasting glucose, 120 minute post-load glucose, age at diabetes diagnosis, presence of diabetic retinopathy, glycosylated hemoglobin, serum creatinine, albumin, impaired fasting glucose, Impaired glucose tolerance, and fasting insulin of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- StudyEvent: SEV1
- Subject ID, case or control, age, gender, country of birth, BMI, waist of hip ratio, plasma cholesterol, plasma triglycerides, total plasma high density lipoprotein cholesterol, systolic and diastolic blood pressure, smoking, fasting glucose, 120 minute post-load glucose, age at diabetes diagnosis, presence of diabetic retinopathy, glycosylated hemoglobin, serum creatinine, albumin, impaired fasting glucose, Impaired glucose tolerance, and fasting insulin of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Subject ID, consent group, affection status, subject source, and source subject ID of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Subject ID, sample ID, sample source, source sample ID, study ID, and sample use variable obtained from participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Subject ID, gender, age, T2D status, age at diagnosis of diabetes, fasting glucose and insulin, glucose, HbA1C, creatinine, total cholesterol, HDL, triglycerides, height, weight, BMI, hip circumference, waist circumference, systolic blood pressure, diastolic blood pressure, lipid medication, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of sample obtained from participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Sample ID, body site where sample was obtained, analyte type, and tumor status of samples of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
Similar models
Subject ID, case or control, age, gender, country of birth, BMI, waist of hip ratio, plasma cholesterol, plasma triglycerides, total plasma high density lipoprotein cholesterol, systolic and diastolic blood pressure, smoking, fasting glucose, 120 minute post-load glucose, age at diabetes diagnosis, presence of diabetic retinopathy, glycosylated hemoglobin, serum creatinine, albumin, impaired fasting glucose, Impaired glucose tolerance, and fasting insulin of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- StudyEvent: SEV1
- Subject ID, case or control, age, gender, country of birth, BMI, waist of hip ratio, plasma cholesterol, plasma triglycerides, total plasma high density lipoprotein cholesterol, systolic and diastolic blood pressure, smoking, fasting glucose, 120 minute post-load glucose, age at diabetes diagnosis, presence of diabetic retinopathy, glycosylated hemoglobin, serum creatinine, albumin, impaired fasting glucose, Impaired glucose tolerance, and fasting insulin of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Subject ID, consent group, affection status, subject source, and source subject ID of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Subject ID, sample ID, sample source, source sample ID, study ID, and sample use variable obtained from participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Subject ID, gender, age, T2D status, age at diagnosis of diabetes, fasting glucose and insulin, glucose, HbA1C, creatinine, total cholesterol, HDL, triglycerides, height, weight, BMI, hip circumference, waist circumference, systolic blood pressure, diastolic blood pressure, lipid medication, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of sample obtained from participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
- Sample ID, body site where sample was obtained, analyte type, and tumor status of samples of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
C0011849 (UMLS CUI [1,2])
C0205161 (UMLS CUI [1,2])
C0202098 (UMLS CUI [1,2])
C2603343 (UMLS CUI [1,2])